Login / Signup

Correction: Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells.

Yunfei LiaoLulu ChenYong FengJacson ShenYan GaoGregory CoteEdwin ChoyDavid HarmonHenry MankinFrancis HornicekZhenfeng Duan
Published in: Oncotarget (2024)
Keyphrases
  • crispr cas
  • induced apoptosis
  • genome editing
  • cell cycle arrest
  • cancer therapy
  • endoplasmic reticulum stress
  • signaling pathway
  • drug delivery
  • cell proliferation
  • pi k akt